ArticleBMC psychiatry2025
Dermatological manifestations among inpatients with substance use disorders: a comparative study of individuals with alcohol and drug use.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSubstance use disorders (SUD), encompassing alcohol use disorder (AUD) and non-alcohol psychoactive drug use disorder (DUD), are associated not only with psychiatric and systemic health outcomes but also with dermatological manifestations. Nevertheless, such cutaneous findings often remain under-recognized. The present study aimed to investigate and compare the prevalence and characteristics of dermatological findings among inpatients with AUD and DUD.
methodsThis descriptive cross-sectional study was conducted at a tertiary psychiatric hospital. The 109 hospitalized patients were categorized into two groups based on their primary diagnosis: AUD (n = 33) and DUD (n = 76). Clinical data included sociodemographic features, substance use characteristics, and comorbidities. Dermatological diagnoses were established through physical examination and classified according to ICD-10.
resultsDermatological conditions were identified in nearly all participants (AUD:100%, DUD:94.7%). However, almost half (43.1%) reported no dermatological complaints beforehand, and a majority (60.6%) had never sought dermatological care. Xerosis (24.2%/7.9%), dermatophytosis (78.8%/57.9%), rosacea (36.4%/2.6%), and mucosal findings (100%/82.9%) were significantly more frequent in AUD. In contrast, hesitation marks (48.7%/9.1%), dermatitis artefacta (78.9%/51.5), sequelae of burns (0%/13.2%) and track marks/sooting tattoos (0%/22.4%) were significantly more common in DUD. Tattoos were more prevalent in patients with DUD (p = 0.018), and correlated with hesitation marks (p < 0.001). All cases of hepatitis B, C, and HIV occurred in the DUD group.
conclusionDermatological conditions are common among inpatients with SUD and show distinct profiles between AUD and DUD, yet they are often overlooked in psychiatric settings. Integrating dermatological evaluations into routine care may enhance early detection, prevent complications, and support comprehensive treatment. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.